Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, D Tsoutsos, H Kalofonos, et al.
Progress in Retinal and Eye Research|October 20, 2025
Clinical histopathology and pathogenesis of macular telangiectasia type 2Dimitrios P Ntentakis, Anastasia Maria Ntentaki, Eleni Delavogia, et al.
Human Mutation|September 12, 2000
BRCA1 mutation analysis in breast/ovarian cancer families from GreeceI Konstantopoulou, C Kroupis, A Ladopoulou, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularizationTakashi Ueta, Kenji Ishihara, Shoji Notomi, et al.
ESMO Open|May 14, 2024
Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documentsE Efstathiou, A Merseburger, A Liew, et al.
Scientific Reports|January 12, 2018
Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular DegenerationCassandra Kosmidou, Nikolaos E Efstathiou, Mien V Hoang, et al.
Cancer Letters|July 27, 2002
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observedA Ladopoulou, C Kroupis, I Konstantopoulou, et al.
Oncogene|July 8, 2014
Autophagy mediates HIF2α degradation and suppresses renal tumorigenesisX-D Liu, J Yao, D N Tripathi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2019
Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retinaShoji Notomi, Kenji Ishihara, Nikolaos E Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2023
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trialK N Chi, S Sandhu, M R Smith, et al.
Pageof 8